Clinical navigation · a second set of eyes
The second opinion script: when to get one, who to ask, and the exact words that make it useful
Second opinions in GLP-1 care are underused because patients treat them as betrayal and overpriced because they arrive unprepared. The triggers that legitimately earn one: a plateau that survived the full audit; side effects unresolved by the standard playbook; complex comorbidities your async platform handles thinly; conflicting advice between clinicians; and the big forks — switching, stopping, or a surgical runway. Who: obesity-medicine specialists (ABOM-certified is the searchable credential), endocrinology for the metabolic-complexity cases, with your PCP as quarterback — the specialist-access file maps the routes. The script to your current provider is one unremarkable sentence — “I’d like a second opinion on [X]; please share my records” — and the script to the consultant is a one-page brief built from your archive: dose history, response curve, symptom log, and one specific question. What good sounds like, what the red flags are, and how to integrate conflicting answers — below.
The five triggers — when a second set of eyes pays
The audited plateau: you ran the three-drift audit clean, you’re at maximum tolerated dose, and the trajectory still argues with the trials — that’s specialist territory, not another month of hoping. Unresolved side effects: the standard moves (timing, titration pace, the sibling molecule) tried, the symptom persisting — a fresh differential beats endurance. Comorbidity complexity: thyroid disease, significant kidney or GI history, a medication list with interaction potential — async questionnaires triage these; specialists actually manage them. Conflicting advice: when your telehealth prescriber and your PCP point different directions, a third clinician resolves by reasoning, not by vote. The forks: molecule switches, planned exits, pregnancy timelines, surgical runways — decisions expensive to get wrong and cheap to get reviewed. Notice what’s absent: routine care going fine. Second opinions are instruments, not rituals — the renewal review covers the annual once-over.
Who to ask — credentials that mean something
Obesity-medicine physicians — the American Board of Obesity Medicine certification is the specific, searchable signal that a clinician chose this field rather than inherited it; directories filter by it, and telehealth second-opinion visits exist at ordinary E&M price points (sometimes insurance-covered as consultations — worth one eligibility call). Endocrinology when the metabolic picture is genuinely tangled — diabetes management alongside, thyroid complexity, PCOS layers. Your PCP as quarterback — even when not the specialist, the clinician who holds your whole chart is where opinions get reconciled, and looping them costs one records-share. Where not to shop for it: the comment section (calibration, never adjudication), and — subtly — a competing weight-loss program’s “free consultation,” which is a sales funnel wearing a stethoscope; real second opinions bill like medicine because they are.
The two scripts — verbatim, adaptable
To your current provider (message, not confession): “Hi — before we decide on [the dose change / switching / stopping], I’d like a second opinion from an obesity-medicine specialist. Please share my records — dose history, notes, and labs — or point me to the export. I’ll loop back with what I learn.” No apology, no justification — records portability is your right and routine; a provider who bristles at this sentence has volunteered data for your renewal review. To the consultant (the one-page brief, attached ahead): “Context: [molecule] since [date], titrated [path], currently [dose]. Response: [start → current weight, with the curve’s shape — steady / stalled since month X]. Tolerability: [the honest line]. Relevant history: [conditions, medications]. My specific question: [one sentence — e.g., ‘given a clean adherence audit and max tolerated dose, is a switch to tirzepatide the evidence-based next step, or is this my maintenance range?’]” The one-question discipline is the whole trick — consultations that open with a question end with an answer; ones that open with a story end with sympathy.
Good, bad, and red-flag — grading the opinion you paid for
A good second opinion engages your specifics (quotes your numbers back, asks follow-ups), explains its reasoning against evidence you can look up, distinguishes “what I’d do” from “what’s defensible either way,” and — tellingly — sometimes endorses your current plan, because “your prescriber’s approach is sound; here’s the one adjustment I’d consider” is the sound of a consultant with nothing to sell. A weak one stays generic — restated guidelines untethered to your chart. The red flags: reflexive trash-talk of your current provider before reading the file; an immediate pivot to enrolling you in their program (the consultation-as-funnel again); certainty without reasoning; and any “opinion” that skips your records entirely. You’re grading process, not verdict — a consultant who disagrees with you carefully outranks one who agrees with you lazily.
Integrating conflict — when the opinions disagree
Two clinicians, two answers: the tiebreak procedure is evidence-plus-values, quarterbacked. First, separate factual disagreement (“the data supports X”) from judgment disagreement (“given your priorities, I’d weight Y”) — most conflicts are the second kind wearing the first kind’s clothes, and your values legitimately decide those. Second, route both write-ups to your PCP with the question “help me reconcile these” — the whole-chart clinician earns the tiebreaker role. Third, whatever’s chosen, document the reasoning in the archive and set the review date — a decision with a scheduled re-examination is allowed to be imperfect. And the meta-rule that keeps the whole exercise honest: you sought a second opinion to improve the decision, not to shop until someone said what you’d already decided — if three clinicians converge against your preference, that convergence is the answer, delivered expensively enough to trust.
FAQ
When should I get a second opinion on GLP-1 treatment?
After a clean-audit plateau at max tolerated dose, for unresolved side effects, complex comorbidities, conflicting advice, or the big forks — switching, stopping, pregnancy timing, surgical runways.
Will my telehealth provider be offended if I seek a second opinion?
Records-sharing requests are routine and your right; a one-line message suffices, and any friction it generates is itself useful information about the provider.
What should I bring to a second-opinion visit?
A one-page brief from your archive — dose history, response curve, tolerability line, relevant history — ending in one specific question.